EW vs FDMT · P/E 47, rev $1.39B vs rev $37.0K
Edwards Lifesciences Corp (EW) versus 4D Molecular Therapeutics Inc (FDMT) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
EW currently screens at market cap $49.91B and trailing P/E 46.9. FDMT currently screens at market cap $518.1M.
Not investment advice. Open the EW and FDMT stock pages for the full models.
Not investment advice.